![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChemCID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C20H19NO5 |
Molar mass | 353.374 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
LY-344,545 is a research drug developed by the pharmaceutical companyEli Lilly, which acts as anantagonist for themetabotropic glutamate receptor subtypemGluR5. It is anepimer of another metabotropic glutamate receptor antagonist, themGluR2/3-selectiveLY-341,495.[1][2]
![]() | Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |